Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised, Double-Blind Placebo Controlled Trial Comparing the Effect of Intravenous Ferric Carboxymaltose on Hospitalisations and Mortality in Iron Deficient Patients Admitted for Acute Heart Failure (Affirm-AHF)

NCT02937454 is registered in ClinicalTrials.gov with Vifor (International) Inc. as lead sponsor.

NCT NCT02937454
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02937454 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised, Double-Blind Placebo Controlled Trial Comparing the Effect of Intravenous Ferric Carboxymaltose on Hospitalisations and Mortality in Iron Deficient Patients Admitted for Acute Heart Failure (Affirm-AHF)
Lead sponsor
Vifor (International) Inc.
Phase
Phase 4
Overall status
Completed
Start date
April 3, 2017
Completion date
July 21, 2020
Enrollment
1,132 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure, iron deficiency